Phase II Study for Solid Metastatic Tumors

NCT02474186 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic Breast Cancer
Solid Tumor

Interventions

RADIATION: Radiation therapy
DRUG: Xeloda
DRUG: paclitaxel

Sponsor

NYU Langone Health